MMP inhibitors function by binding to the active site of MMPs, thereby preventing these enzymes from interacting with their substrates. This inhibition can be achieved through various mechanisms, such as competitive inhibition, where the inhibitor competes with the substrate for binding to the enzyme's active site. By blocking MMP activity, these inhibitors aim to prevent the degradation of the extracellular matrix, thereby limiting tumor invasion and metastasis.
